Drug Shortage Report for AURO-TENOFOVIR
| Report ID | 207412 |
| Drug Identification Number | 02460173 |
| Brand name | AURO-TENOFOVIR |
| Common or Proper name | Auro-Tenofovir 300mg |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TENOFOVIR DISOPROXIL FUMARATE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30's |
| ATC code | J05AF |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-10-19 |
| Actual start date | 2023-10-23 |
| Estimated end date | 2023-11-15 |
| Actual end date | 2023-11-10 |
| Shortage status | Resolved |
| Updated date | 2023-11-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-11-11 | English | Compare |
| v6 | 2023-11-10 | French | Compare |
| v5 | 2023-11-10 | English | Compare |
| v4 | 2023-11-10 | English | Compare |
| v3 | 2023-10-24 | English | Compare |
| v2 | 2023-10-19 | French | Compare |
| v1 | 2023-10-19 | English | Compare |
Showing 1 to 7 of 7